Future studies should focus on measuring CST among similar cohorts of HF patients, taking into account their clinical parameters, variability of CgA metabolism, medical history and pharmacotherapy (including new-generation drugs such as levosimendan [38] and proprotein convertase subtilisin/kexin 9 inhibitors [39]). Here, CGA is linked to hydrops fetalis.